ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 70 filers reported holding ANTARES PHARMA INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $180,000 | +14.6% | 44,000 | 0.0% | 0.05% | +15.0% |
Q4 2021 | $157,000 | -1.9% | 44,000 | 0.0% | 0.04% | -11.1% |
Q3 2021 | $160,000 | -23.4% | 44,000 | -8.3% | 0.04% | -21.1% |
Q2 2021 | $209,000 | -12.2% | 48,000 | -17.2% | 0.06% | -17.4% |
Q1 2021 | $238,000 | -0.4% | 58,000 | -3.3% | 0.07% | -9.2% |
Q4 2020 | $239,000 | +47.5% | 60,000 | 0.0% | 0.08% | +16.9% |
Q3 2020 | $162,000 | -1.8% | 60,000 | 0.0% | 0.06% | -11.0% |
Q2 2020 | $165,000 | +16.2% | 60,000 | 0.0% | 0.07% | -6.4% |
Q1 2020 | $142,000 | -49.6% | 60,000 | 0.0% | 0.08% | -32.2% |
Q4 2019 | $282,000 | +40.3% | 60,000 | 0.0% | 0.12% | +35.3% |
Q3 2019 | $201,000 | +2.0% | 60,000 | 0.0% | 0.08% | +1.2% |
Q2 2019 | $197,000 | +8.2% | 60,000 | 0.0% | 0.08% | +2.4% |
Q1 2019 | $182,000 | +11.7% | 60,000 | 0.0% | 0.08% | -1.2% |
Q4 2018 | $163,000 | -19.3% | 60,000 | 0.0% | 0.08% | +6.4% |
Q3 2018 | $202,000 | +30.3% | 60,000 | 0.0% | 0.08% | +21.9% |
Q2 2018 | $155,000 | +17.4% | 60,000 | 0.0% | 0.06% | -5.9% |
Q1 2018 | $132,000 | +10.9% | 60,000 | 0.0% | 0.07% | +41.7% |
Q4 2017 | $119,000 | -38.7% | 60,000 | 0.0% | 0.05% | -41.5% |
Q3 2017 | $194,000 | +0.5% | 60,000 | 0.0% | 0.08% | +5.1% |
Q2 2017 | $193,000 | +13.5% | 60,000 | 0.0% | 0.08% | +25.8% |
Q1 2017 | $170,000 | +38.2% | 60,000 | 0.0% | 0.06% | +31.9% |
Q4 2016 | $123,000 | +95.2% | 60,000 | 0.0% | 0.05% | +56.7% |
Q3 2016 | $63,000 | 0.0% | 60,000 | 0.0% | 0.03% | +3.4% |
Q2 2016 | $63,000 | +21.2% | 60,000 | 0.0% | 0.03% | +20.8% |
Q1 2016 | $52,000 | -28.8% | 60,000 | 0.0% | 0.02% | -31.4% |
Q4 2015 | $73,000 | -28.4% | 60,000 | 0.0% | 0.04% | -28.6% |
Q3 2015 | $102,000 | -18.4% | 60,000 | 0.0% | 0.05% | -3.9% |
Q2 2015 | $125,000 | +83.8% | 60,000 | +140.0% | 0.05% | +82.1% |
Q1 2015 | $68,000 | +6.2% | 25,000 | 0.0% | 0.03% | +7.7% |
Q4 2014 | $64,000 | +39.1% | 25,000 | 0.0% | 0.03% | +30.0% |
Q3 2014 | $46,000 | -31.3% | 25,000 | 0.0% | 0.02% | -25.9% |
Q2 2014 | $67,000 | -23.0% | 25,000 | 0.0% | 0.03% | -28.9% |
Q1 2014 | $87,000 | -22.3% | 25,000 | 0.0% | 0.04% | -22.4% |
Q4 2013 | $112,000 | +10.9% | 25,000 | 0.0% | 0.05% | 0.0% |
Q3 2013 | $101,000 | -19.2% | 25,000 | -16.7% | 0.05% | -24.6% |
Q2 2013 | $125,000 | – | 30,000 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JW Asset Management, LLC | 1,671,956 | $5,384,000 | 3.43% |
ARMISTICE CAPITAL, LLC | 5,700,000 | $18,354,000 | 2.34% |
Rubric Capital Management LP | 3,188,600 | $10,267,000 | 2.12% |
Broadfin Capital, LLC | 4,803,528 | $15,467,000 | 1.88% |
THOMPSON DAVIS & CO., INC. | 192,734 | $621,000 | 1.00% |
Asymmetry Capital Management, L.P. | 199,655 | $643,000 | 0.76% |
Perceptive Advisors | 4,267,253 | $13,741,000 | 0.69% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 946,987 | $3,049,000 | 0.21% |
Brown Advisory Securities, LLC | 275,000 | $886,000 | 0.20% |
EAM Investors, LLC | 251,619 | $810,000 | 0.13% |